Latest Breaking News On - Sinaptica therapeutics - Page 1 : comparemela.com

Bill Gates: Health Care 'At a Tipping Point' on Alzheimer's Disease

Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer's | Region

CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 28, 2024

Sinaptica Looks to Treat Alzheimer's Disease Symptoms with Device

Sinaptica said it has won breakthrough device designation for its SinaptiStim technology.

Novel Approach to TMS May Slow Cognitive Decline in Alzheimer's

By targeting the precuneus in patients with Alzheimer s disease, investigators using rTMS are hoping to stimulate or repair neural connections in the default mode network.

Sinaptica Therapeutics Announces Publication of Positive Results from Phase II Trial Evaluating the Potential of Precision-Delivered Noninvasive Neurostimulation Treatment for Mild-to-Moderate Alzheimer's Disease

Sinaptica Therapeutics Announces Publication of Positive Results from Phase II Trial Evaluating the Potential of Precision-Delivered Noninvasive Neurostimulation Treatment for Mild-to-Moderate Alzheimer’s Disease - read this article along with other careers information, tips and advice on BioSpace